Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 10/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4261922 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL4259425 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL5895085 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL10059872 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL5895055 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL5896208 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL4261969 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL3398722 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL4258523 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP1A2PPARGEPHX1GRM2 | |
| SCHEMBL4260024 | 0.98 | ALDH1A1 (0.43) | ALDH1A1CYP1A2PPARGEPHX1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7094865-B2 | Thiophenes and polymers derived therefrom | AGFA GEVAERT (BE) | 2006-08-22 | — | — | US | disclosed |
| EP-1390422-B1 | THIOPHENES AND POLYMERS DERIVED THEREFROM | AGFA GEVAERT (BE) | 2004-11-03 | — | — | EP | disclosed |
| US-20030055130-A1 | New thiophenes and polymers derived therefrom | AGFA-GEVAERT (BE) | 2003-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055130-A1 | New thiophenes and polymers derived therefrom | NOTUM, WEE1, THEM6 | ALDH1A1 136/4885CYP1A2 96/4885PPARG 3154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.